Overview

Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder

Status:
Not yet recruiting
Trial end date:
2025-01-31
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to assess the safety and efficacy of psilocybin-assisted therapy in the treatment of post-traumatic stress disorder in United States military Veterans.
Phase:
Phase 2
Details
Lead Sponsor:
Ohio State University
Treatments:
Psilocybin